Literature DB >> 11081894

In vivo gene gun-mediated transduction into rat heart with Epstein-Barr virus-based episomal vectors.

K Nishizaki1, O Mazda, Y Dohi, T Kawata, K Mizuguchi, S Kitamura, S Taniguchi.   

Abstract

BACKGROUND: Gene guns have been used to transfer genes into various organs, but there has been no report of successful gene gun-mediated gene transfer into the heart. In this study, we assessed the possibility of gene therapy using a gene gun and an episomal plasmid vector.
METHODS: Gene transfer was performed using two sizes of gold particles and two plasmids (an episomal vector and a conventional plasmid vector). From the first to eighth week after the bombardment, rats were sacrificed. The excised hearts were subjected to X-gal staining and histologic examination. To ensure that plasmid was not distributed to organs other than the heart, the presence of the beta-gal sequence was examined by polymerase chain reaction analyses.
RESULTS: Gene expression persisted for 6 weeks. The episomal vector apparently contributed to long-lasting expression. Infiltration of monocytes or leukocytes was very faint. The beta-gal DNA was detected in bombarded hearts but not other organs.
CONCLUSIONS: Gene gun-mediated transfer of the episomal vector into beating heart may provide a simple, efficient, and useful strategy for gene therapy.

Entities:  

Mesh:

Year:  2000        PMID: 11081894     DOI: 10.1016/s0003-4975(00)01708-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.

Authors:  M G Katz; A S Fargnoli; R J Hajjar; C R Bridges
Journal:  Expert Opin Drug Deliv       Date:  2017-06-22       Impact factor: 6.648

Review 2.  Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability.

Authors:  Michael G Katz; Anthony S Fargnoli; Charles R Bridges
Journal:  Hum Gene Ther       Date:  2013-04-01       Impact factor: 5.695

3.  A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression.

Authors:  A S Fargnoli; M G Katz; R D Williams; K B Margulies; Charles R Bridges
Journal:  J Cardiovasc Transl Res       Date:  2014-10-15       Impact factor: 4.132

4.  Response to the letter to the editor: delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.

Authors:  M Maslov; S Foianini; M Lovich
Journal:  Expert Opin Drug Deliv       Date:  2017-07       Impact factor: 6.648

Review 5.  Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.

Authors:  Michael G Katz; Anthony S Fargnoli; Richard D Williams; Charles R Bridges
Journal:  Hum Gene Ther       Date:  2013-11       Impact factor: 5.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.